Skip to content

Harrow HROW Amount that if recognized, would affect the effective tax rate or regulatory liability

Amount that if recognized, would affect the effective tax rate or regulatory liability at other companies

Bausch + Lomb logo
Bausch + LombBLCO
Bausch Health Companies logo
Bausch Health CompaniesBHC
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.8B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate.

The official record: Harrow’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's amount that if recognized, would affect the effective tax rate or regulatory liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's amount that if recognized, would affect the effective tax rate or regulatory liability?
Harrow (HROW) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $307K in Q4 2025.
What is the long-term trend for Harrow's amount that if recognized, would affect the effective tax rate or regulatory liability?
Over 2 years (2023 to 2025), Harrow's amount that if recognized, would affect the effective tax rate or regulatory liability has grown at a -67.0% compound annual growth rate (CAGR), from $2.82M to $307K.